Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Groisberg

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Cancers|October 23, 2021
Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue SarcomaJason Roszik, Lisa Maria Mustachio, John A Livingston, et al.
Current Problems in Cancer|October 17, 2021
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implicationsRoberto Carmagnani Pestana, Jason Roszik, Roman Groisberg, et al.
Molecular Cancer Therapeutics|April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersRoman Groisberg, David S Hong, Jason Roszik, et al.
Cancers|September 5, 2019
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy TargetsJason Roszik, Abir Khan, Anthony P Conley, et al.
Annals of Surgical Oncology|January 24, 2021
Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous MelanomaAaron W Kangas-Dick, Alissa Greenbaum, Victor Gall, et al.
Journal of Kidney Cancer and VHL|May 18, 2022
Massive Malignant Epithelioid Angiomyolipoma of the KidneyIsaac M Tessone, Benjamin Lichtbroun, Arnav Srivastava, et al.
Nature Communications|January 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trialRobin L Jones, Roman Groisberg, Jean-Yves Blay, et al.
Journal for Immunotherapy of Cancer|October 6, 2020
Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancerShang-Jui Wang, Karishma Khullar, Sinae Kim, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
Molecular Cancer Therapeutics|March 5, 2020
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental TherapiesRoman Groisberg, Jason Roszik, Anthony P Conley, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Cancers|October 23, 2021
Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue SarcomaJason Roszik, Lisa Maria Mustachio, John A Livingston, et al.
Current Problems in Cancer|October 17, 2021
Discovery of targeted expression data for novel antibody-based and chimeric antigen receptor-based therapeutics in soft tissue sarcomas using RNA-sequencing: clinical implicationsRoberto Carmagnani Pestana, Jason Roszik, Roman Groisberg, et al.
Molecular Cancer Therapeutics|April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersRoman Groisberg, David S Hong, Jason Roszik, et al.
Cancers|September 5, 2019
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy TargetsJason Roszik, Abir Khan, Anthony P Conley, et al.
Annals of Surgical Oncology|January 24, 2021
Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous MelanomaAaron W Kangas-Dick, Alissa Greenbaum, Victor Gall, et al.
Journal of Kidney Cancer and VHL|May 18, 2022
Massive Malignant Epithelioid Angiomyolipoma of the KidneyIsaac M Tessone, Benjamin Lichtbroun, Arnav Srivastava, et al.
Nature Communications|January 29, 2026
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trialRobin L Jones, Roman Groisberg, Jean-Yves Blay, et al.
Journal for Immunotherapy of Cancer|October 6, 2020
Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancerShang-Jui Wang, Karishma Khullar, Sinae Kim, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
Molecular Cancer Therapeutics|March 5, 2020
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental TherapiesRoman Groisberg, Jason Roszik, Anthony P Conley, et al.
Pageof 4